Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.
Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, Worthylake D, Garai J, Zabaleta J, Guidry J, Zarandi MA, Wyczechowska D, Jayawickramarajah J, Yang Q, Kissil J, Alahari SK. Yousefi H, et al. Among authors: guidry j. Oncogene. 2022 Nov;41(47):5076-5091. doi: 10.1038/s41388-022-02497-2. Epub 2022 Oct 15. Oncogene. 2022. PMID: 36243802
Regulation of ROCKII by localization to membrane compartments and binding to DynaminI.
Tumusiime S, Rana MK, Kher SS, Kurella VB, Williams KA, Guidry JJ, Worthylake DK, Worthylake RA. Tumusiime S, et al. Among authors: guidry jj. Biochem Biophys Res Commun. 2009 Apr 10;381(3):393-6. doi: 10.1016/j.bbrc.2009.02.056. Epub 2009 Feb 15. Biochem Biophys Res Commun. 2009. PMID: 19222995 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35553863
[No title available]
[No authors listed] [No authors listed] PMID: 35555165
[No title available]
[No authors listed] [No authors listed] PMID: 35556634
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.
Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, Worthylake D, Garai J, Zabaleta J, Guidry J, Zarandi MA, Wyczechowska D, Jayawickramarajah J, Yang Q, Kissil J, Alahari SK. Yousefi H, et al. Among authors: guidry j. Oncogene. 2023 Mar;42(11):859. doi: 10.1038/s41388-023-02608-7. Oncogene. 2023. PMID: 36759576 No abstract available.
199 results